Coherus Oncology, Inc. (CHRS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 170.92M |
| Enterprise Value | 122.38M |
| P/E Ratio | -1.2 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 4.02 |
| Price/Book Ratio | 2.67 |
| Enterprise/Revenue | 2.72 |
| Enterprise/EBITDA | -0.8 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -3.23 |
| Operating Margin | -3.62 |
AD
Management Effectiveness
| Return On Assets | -0.57 |
| Return On Equity | -1.75 |
Income Statement
| Revenue | 42.17M |
| Revenue/Share | 0.34 |
| Gross Profit | 24.43M |
| EBITDA | -170.2M |
| Net Income | -170.29M |
| Diluted EPS | -1.45 |
Balance Sheet
| Total Cash | 167.05M |
| Total Cash/Share | 1.22 |
| Total Debt | 54.37M |
| Total Debt/Equity | 0.69 |
| Current Ratio | 1.56 |
| Book Value Per Share | 0.58 |
Price History
| 52-Week Change | 62.16 |
| 52-Week High | 2.62 |
| 52-Week Low | 0.81 |
| Moving Average 50 Days | 1.57 |
| Moving Average 200 Days | 1.62 |
Statistics
| Average Volume | 1.17M |
| Shares Outstanding | 122.41M |
| % Held by Institutions | 49.24 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
